(Q34990027)

5 August 2017

1 reference

title

New directions in the pharmacotherapy of posttraumatic stress disorder (English)

1 reference

post-traumatic stress disorder

5 August 2017

0 references

1 reference

2

Thomas C Neylan

1 reference

5 August 2017

Charles R Marmar

1

1 reference

PubMed ID

12418356

5 August 2017

Frank B Schoenfeld

series ordinal

3

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

Psychiatric Quarterly

1 reference

5 August 2017

73

1 reference

5 August 2017

4

1 reference

5 August 2017

259-270

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1020459916113

5 August 2017

0 references

cites work

Nightmares treated with cyproheptadine.

1 reference

12 December 2020

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment

1 reference

12 December 2020

Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial

1 reference

12 December 2020

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

12 December 2020

Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy

1 reference

12 December 2020

The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases.

1 reference

12 December 2020

Fluvoxamine and sleep disturbances in posttraumatic stress disorder

1 reference

12 December 2020

Cyproheptadine for posttraumatic nightmares

1 reference

12 December 2020

Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study

1 reference

12 December 2020

Neurotransmitter alterations in PTSD: catecholamines and serotonin

1 reference

12 December 2020

An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder

1 reference

12 December 2020

Clonidine for posttraumatic stress disorder in preschool children

1 reference

12 December 2020

Carbamazepine for PTSD

1 reference

12 December 2020

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

12 December 2020

Psychopharmacology of pediatric posttraumatic stress disorder

1 reference

12 December 2020

Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes

1 reference

12 December 2020

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

12 December 2020

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

1 reference

12 December 2020

Beta-adrenergic activation and memory for emotional events

1 reference

12 December 2020

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial

1 reference

12 December 2020

An open trial of moclobemide in the treatment of post-traumatic stress disorder

1 reference

12 December 2020

Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder.

1 reference

12 December 2020

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

12 December 2020

The suppression of nightmares with guanfacine

1 reference

12 December 2020

Olanzapine treatment for post-traumatic stress disorder: an open-label study

1 reference

12 December 2020

Clonidine in Cambodian patients with posttraumatic stress disorder

1 reference

12 December 2020

Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder

1 reference

12 December 2020

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

1 reference

12 December 2020

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

1 reference

12 December 2020

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

1 reference

12 December 2020

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment

1 reference

12 December 2020

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

1 reference

12 December 2020

Fluoxetine in posttraumatic stress disorder

1 reference

12 December 2020

Nefazodone in post-traumatic stress disorder: results from six open-label trials

1 reference

12 December 2020

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

12 December 2020

Nefazodone treatment and dream reports in chronic PTSD.

1 reference

12 December 2020

Valproate in combat-related posttraumatic stress disorder.

1 reference

12 December 2020

Lithium for irritability in post-traumatic stress disorder.

1 reference

12 December 2020

Treatment of recent trauma survivors with benzodiazepines: a prospective study.

1 reference

12 December 2020

Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment

1 reference

12 December 2020

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020459916113

1 reference

PubMed ID

12418356

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12418356